Iclusig (ponatinib)

pCPA File Number: 20834
Negotiation Status:
Concluded with an LOI
Indication(s):
Chronic Myeloid Leukemia/Acute Lymphoblastic Leukemia
Sponsor/Manufacturer:
Paladin Labs Inc.
CDA-AMC Project Number:
PC0056-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: